Global Recombinant Antibody Market Growth (Status and Outlook) 2024-2030

December 2024 | 90 pages | ID: G9E195E8B4F8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Recombinant Antibody market size was valued at US$ 183.9 million in 2023. With growing demand in downstream market, the Recombinant Antibody is forecast to a readjusted size of US$ 202 million by 2030 with a CAGR of 1.3% during review period.

The research report highlights the growth potential of the global Recombinant Antibody market. Recombinant Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Recombinant Antibody. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Recombinant Antibody market.

Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.

The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.

Key Features:

The report on Recombinant Antibody market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Recombinant Antibody market. It may include historical data, market segmentation by Type (e.g., Chimeric Antibody, Humanized Antibody), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Recombinant Antibody market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Recombinant Antibody market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Recombinant Antibody industry. This include advancements in Recombinant Antibody technology, Recombinant Antibody new entrants, Recombinant Antibody new investment, and other innovations that are shaping the future of Recombinant Antibody.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Recombinant Antibody market. It includes factors influencing customer ' purchasing decisions, preferences for Recombinant Antibody product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Recombinant Antibody market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Recombinant Antibody market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Recombinant Antibody market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Recombinant Antibody industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Recombinant Antibody market.

Market Segmentation:

Recombinant Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Chimeric Antibody
• Humanized Antibody
• Full Human Antibody
• Single Chain Antibody
• Bispecific Antibody

Segmentation by application

• Hospital
• Scientific Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abnova
• Medix Biochemica
• GE Healthcare
• SinoBiological
• Bioventix

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Antibody Market Size 2019-2030
  2.1.2 Recombinant Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Recombinant Antibody Segment by Type
  2.2.1 Chimeric Antibody
  2.2.2 Humanized Antibody
  2.2.3 Full Human Antibody
  2.2.4 Single Chain Antibody
  2.2.5 Bispecific Antibody
2.3 Recombinant Antibody Market Size by Type
  2.3.1 Recombinant Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Recombinant Antibody Market Size Market Share by Type (2019-2024)
2.4 Recombinant Antibody Segment by Application
  2.4.1 Hospital
  2.4.2 Scientific Research
  2.4.3 Others
2.5 Recombinant Antibody Market Size by Application
  2.5.1 Recombinant Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Recombinant Antibody Market Size Market Share by Application (2019-2024)

3 RECOMBINANT ANTIBODY MARKET SIZE BY PLAYER

3.1 Recombinant Antibody Market Size Market Share by Players
  3.1.1 Global Recombinant Antibody Revenue by Players (2019-2024)
  3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT ANTIBODY BY REGIONS

4.1 Recombinant Antibody Market Size by Regions (2019-2024)
4.2 Americas Recombinant Antibody Market Size Growth (2019-2024)
4.3 APAC Recombinant Antibody Market Size Growth (2019-2024)
4.4 Europe Recombinant Antibody Market Size Growth (2019-2024)
4.5 Middle East & Africa Recombinant Antibody Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Recombinant Antibody Market Size by Country (2019-2024)
5.2 Americas Recombinant Antibody Market Size by Type (2019-2024)
5.3 Americas Recombinant Antibody Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Antibody Market Size by Region (2019-2024)
6.2 APAC Recombinant Antibody Market Size by Type (2019-2024)
6.3 APAC Recombinant Antibody Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Antibody by Country (2019-2024)
7.2 Europe Recombinant Antibody Market Size by Type (2019-2024)
7.3 Europe Recombinant Antibody Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Antibody by Region (2019-2024)
8.2 Middle East & Africa Recombinant Antibody Market Size by Type (2019-2024)
8.3 Middle East & Africa Recombinant Antibody Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT ANTIBODY MARKET FORECAST

10.1 Global Recombinant Antibody Forecast by Regions (2025-2030)
  10.1.1 Global Recombinant Antibody Forecast by Regions (2025-2030)
  10.1.2 Americas Recombinant Antibody Forecast
  10.1.3 APAC Recombinant Antibody Forecast
  10.1.4 Europe Recombinant Antibody Forecast
  10.1.5 Middle East & Africa Recombinant Antibody Forecast
10.2 Americas Recombinant Antibody Forecast by Country (2025-2030)
  10.2.1 United States Recombinant Antibody Market Forecast
  10.2.2 Canada Recombinant Antibody Market Forecast
  10.2.3 Mexico Recombinant Antibody Market Forecast
  10.2.4 Brazil Recombinant Antibody Market Forecast
10.3 APAC Recombinant Antibody Forecast by Region (2025-2030)
  10.3.1 China Recombinant Antibody Market Forecast
  10.3.2 Japan Recombinant Antibody Market Forecast
  10.3.3 Korea Recombinant Antibody Market Forecast
  10.3.4 Southeast Asia Recombinant Antibody Market Forecast
  10.3.5 India Recombinant Antibody Market Forecast
  10.3.6 Australia Recombinant Antibody Market Forecast
10.4 Europe Recombinant Antibody Forecast by Country (2025-2030)
  10.4.1 Germany Recombinant Antibody Market Forecast
  10.4.2 France Recombinant Antibody Market Forecast
  10.4.3 UK Recombinant Antibody Market Forecast
  10.4.4 Italy Recombinant Antibody Market Forecast
  10.4.5 Russia Recombinant Antibody Market Forecast
10.5 Middle East & Africa Recombinant Antibody Forecast by Region (2025-2030)
  10.5.1 Egypt Recombinant Antibody Market Forecast
  10.5.2 South Africa Recombinant Antibody Market Forecast
  10.5.3 Israel Recombinant Antibody Market Forecast
  10.5.4 Turkey Recombinant Antibody Market Forecast
  10.5.5 GCC Countries Recombinant Antibody Market Forecast
10.6 Global Recombinant Antibody Forecast by Type (2025-2030)
10.7 Global Recombinant Antibody Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Abnova
  11.1.1 Abnova Company Information
  11.1.2 Abnova Recombinant Antibody Product Offered
  11.1.3 Abnova Recombinant Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Abnova Main Business Overview
  11.1.5 Abnova Latest Developments
11.2 Medix Biochemica
  11.2.1 Medix Biochemica Company Information
  11.2.2 Medix Biochemica Recombinant Antibody Product Offered
  11.2.3 Medix Biochemica Recombinant Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Medix Biochemica Main Business Overview
  11.2.5 Medix Biochemica Latest Developments
11.3 GE Healthcare
  11.3.1 GE Healthcare Company Information
  11.3.2 GE Healthcare Recombinant Antibody Product Offered
  11.3.3 GE Healthcare Recombinant Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 GE Healthcare Main Business Overview
  11.3.5 GE Healthcare Latest Developments
11.4 SinoBiological
  11.4.1 SinoBiological Company Information
  11.4.2 SinoBiological Recombinant Antibody Product Offered
  11.4.3 SinoBiological Recombinant Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 SinoBiological Main Business Overview
  11.4.5 SinoBiological Latest Developments
11.5 Bioventix
  11.5.1 Bioventix Company Information
  11.5.2 Bioventix Recombinant Antibody Product Offered
  11.5.3 Bioventix Recombinant Antibody Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bioventix Main Business Overview
  11.5.5 Bioventix Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES
.
Table 1. Recombinant Antibody Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chimeric Antibody
Table 3. Major Players of Humanized Antibody
Table 4. Major Players of Full Human Antibody
Table 5. Major Players of Single Chain Antibody
Table 6. Major Players of Bispecific Antibody
Table 7. Recombinant Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Recombinant Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Recombinant Antibody Market Size Market Share by Type (2019-2024)
Table 10. Recombinant Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Recombinant Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Recombinant Antibody Market Size Market Share by Application (2019-2024)
Table 13. Global Recombinant Antibody Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Recombinant Antibody Revenue Market Share by Player (2019-2024)
Table 15. Recombinant Antibody Key Players Head office and Products Offered
Table 16. Recombinant Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Recombinant Antibody Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Recombinant Antibody Market Size Market Share by Regions (2019-2024)
Table 21. Global Recombinant Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Recombinant Antibody Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Recombinant Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Recombinant Antibody Market Size Market Share by Country (2019-2024)
Table 25. Americas Recombinant Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Recombinant Antibody Market Size Market Share by Type (2019-2024)
Table 27. Americas Recombinant Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Recombinant Antibody Market Size Market Share by Application (2019-2024)
Table 29. APAC Recombinant Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Recombinant Antibody Market Size Market Share by Region (2019-2024)
Table 31. APAC Recombinant Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Recombinant Antibody Market Size Market Share by Type (2019-2024)
Table 33. APAC Recombinant Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Recombinant Antibody Market Size Market Share by Application (2019-2024)
Table 35. Europe Recombinant Antibody Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Recombinant Antibody Market Size Market Share by Country (2019-2024)
Table 37. Europe Recombinant Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Recombinant Antibody Market Size Market Share by Type (2019-2024)
Table 39. Europe Recombinant Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Recombinant Antibody Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Recombinant Antibody Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Recombinant Antibody Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Recombinant Antibody Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Recombinant Antibody Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Recombinant Antibody Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Recombinant Antibody Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Recombinant Antibody
Table 48. Key Market Challenges & Risks of Recombinant Antibody
Table 49. Key Industry Trends of Recombinant Antibody
Table 50. Global Recombinant Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Recombinant Antibody Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Recombinant Antibody Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Recombinant Antibody Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Abnova Details, Company Type, Recombinant Antibody Area Served and Its Competitors
Table 55. Abnova Recombinant Antibody Product Offered
Table 56. Abnova Recombinant Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Abnova Main Business
Table 58. Abnova Latest Developments
Table 59. Medix Biochemica Details, Company Type, Recombinant Antibody Area Served and Its Competitors
Table 60. Medix Biochemica Recombinant Antibody Product Offered
Table 61. Medix Biochemica Main Business
Table 62. Medix Biochemica Recombinant Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Medix Biochemica Latest Developments
Table 64. GE Healthcare Details, Company Type, Recombinant Antibody Area Served and Its Competitors
Table 65. GE Healthcare Recombinant Antibody Product Offered
Table 66. GE Healthcare Main Business
Table 67. GE Healthcare Recombinant Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. GE Healthcare Latest Developments
Table 69. SinoBiological Details, Company Type, Recombinant Antibody Area Served and Its Competitors
Table 70. SinoBiological Recombinant Antibody Product Offered
Table 71. SinoBiological Main Business
Table 72. SinoBiological Recombinant Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. SinoBiological Latest Developments
Table 74. Bioventix Details, Company Type, Recombinant Antibody Area Served and Its Competitors
Table 75. Bioventix Recombinant Antibody Product Offered
Table 76. Bioventix Main Business
Table 77. Bioventix Recombinant Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Bioventix Latest Developments

List Of Figures

LIST OF FIGURES
.
Figure 1. Recombinant Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Antibody Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Recombinant Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Recombinant Antibody Sales Market Share by Country/Region (2023)
Figure 8. Recombinant Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Recombinant Antibody Market Size Market Share by Type in 2023
Figure 10. Recombinant Antibody in Hospital
Figure 11. Global Recombinant Antibody Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Recombinant Antibody in Scientific Research
Figure 13. Global Recombinant Antibody Market: Scientific Research (2019-2024) & ($ Millions)
Figure 14. Recombinant Antibody in Others
Figure 15. Global Recombinant Antibody Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Recombinant Antibody Market Size Market Share by Application in 2023
Figure 17. Global Recombinant Antibody Revenue Market Share by Player in 2023
Figure 18. Global Recombinant Antibody Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Recombinant Antibody Market Size 2019-2024 ($ Millions)
Figure 20. APAC Recombinant Antibody Market Size 2019-2024 ($ Millions)
Figure 21. Europe Recombinant Antibody Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Recombinant Antibody Market Size 2019-2024 ($ Millions)
Figure 23. Americas Recombinant Antibody Value Market Share by Country in 2023
Figure 24. United States Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Recombinant Antibody Market Size Market Share by Region in 2023
Figure 29. APAC Recombinant Antibody Market Size Market Share by Type in 2023
Figure 30. APAC Recombinant Antibody Market Size Market Share by Application in 2023
Figure 31. China Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Recombinant Antibody Market Size Market Share by Country in 2023
Figure 38. Europe Recombinant Antibody Market Size Market Share by Type (2019-2024)
Figure 39. Europe Recombinant Antibody Market Size Market Share by Application (2019-2024)
Figure 40. Germany Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Recombinant Antibody Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Recombinant Antibody Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Recombinant Antibody Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Recombinant Antibody Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 54. APAC Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 55. Europe Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 57. United States Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 58. Canada Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 61. China Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 62. Japan Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 63. Korea Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 65. India Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 66. Australia Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 67. Germany Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 68. France Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 69. UK Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 70. Italy Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 71. Russia Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 72. Spain Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 75. Israel Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Recombinant Antibody Market Size 2025-2030 ($ Millions)
Figure 78. Global Recombinant Antibody Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Recombinant Antibody Market Size Market Share Forecast by Application (2025-2030)